NUVECTIS PHARMA INC
NVCT·67080T108·US·Common Stock·Healthcare - Biotechnology
NVCT (NUVECTIS PHARMA INC) is held by 41 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($5.9M), VANGUARD CAPITAL MANAGEMENT LLC ($5.1M), GEODE CAPITAL MANAGEMENT, LLC ($3M). Net institutional sentiment: Bullish.
41
Holders
Avg rating(9 Elite)
$22.1M
Total Value
76% (41)
Fund Consensus
26 buying - 8 selling
Who's Trading
InsiderBRBENTSUR RONBuy $29KNov 5, 2025
InsiderKLKaplan Matthew L.Buy $64KNov 5, 2025
InsiderSJSanchez JuanBuy $75KNov 5, 2025
InsiderMCMosseri Marlio CharlesBuy $457KOct 27, 2025
InsiderMCMosseri Marlio CharlesBuy $215KOct 24, 2025
InsiderMCMosseri Marlio CharlesBuy $284KOct 23, 2025
InsiderMCMosseri Marlio CharlesBuy $45KJun 20, 2025
InsiderMCMosseri Marlio CharlesBuy $226KJun 18, 2025
InsiderMCMosseri Marlio CharlesBuy $44KJun 17, 2025
InsiderMCMosseri Marlio CharlesBuy $21KMay 8, 2025
13F: Insider & Congress:
Showing 1-20 of 41
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer